| Key Data | |
|---|---|
| Order year | 1996 |
| Plant type | New plant |
| Location | Schweizerhalle, Switzerland |
| Estimated investment | $103m (CHF170m), 2004 expansion CHF60m, 2006 expansion CHF75m, 2007 expansion CHF300m |
| Completion | 1999, 2004, 2008 |
| Key Players | |
| Sponsor | Novartis |
| Financing | Novartis |
| Output Chemicals | |
| Vials per year | 36 million, increase in Diovan of 60t |
| Ampoules | 160 million |
| Featured Suppliers | |
| CEPHA s.r.o. - Bioavailability and Bioequivalence Studies and Bioanalytical Services | |
| MAVAG - FUNDAŽ-Filter Systems for Pharmaceutical Applications | |
